世界の動物用ワクチン市場：動物疾患、技術、動物、地域別 - 動向および予測
Global Veterinary Vaccines Market Segmented By Veterinary Diseases , By Technology, By Animal Type & By Geography - Trends And Forecast 2016-2021
|発行||Mordor Intelligence LLP||商品コード||319396|
|世界の動物用ワクチン市場：動物疾患、技術、動物、地域別 - 動向および予測 Global Veterinary Vaccines Market Segmented By Veterinary Diseases , By Technology, By Animal Type & By Geography - Trends And Forecast 2016-2021|
|出版日: 2016年01月01日||ページ情報: 英文||
The Global market for Veterinary Vaccines has been estimated at USD 12.12 billion in 2015and is projected to reach USD 20.81 billion by 2020at a CAGR of 9.42% during the forecast period from 2015 to 2020. Veterinary vaccines help to improve health and welfare of animals, increase production of livestock in a cost effective manner and prevent transmission of diseases among animals and also to humans. Efficient animal production and better access to high-quality protein dramatically increase meat and egg production and contribute to greater economic outcome. Also, rapid development of animal vaccines can play an effective role in controlling emerging diseases. Veterinary vaccines comprise only approximately 23% of the global market for animal health products.
Key factors like technological innovations, growing awareness of animal health, increasing investmentsby government bodies and associations are driving the market growth. In addition, increased demand for animal protein, including milk, meat, eggs and fish, increased expenditure on healthcare of companion animals.However, rising maintenance costs for storage of vaccines, increasing adoption of vegetarian food in major economies owing to increasing risk of obesity and other chronic disorders, persistent economic slowdown are key factors limiting the growth of this market.
The veterinary vaccines market is segmented on the basis of products, diseases, technologies and regions. Based on product type, the market is categorized into companion animal vaccines, livestock vaccines, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines and other animal vaccines. Porcine vaccines is the largest sub-segment contributing to major share of the market, whereas companion animal Vaccines is the fastest growing segment due to increasing prevalence of zoonotic diseases in humans and growing pet population. The technology segment includes live attenuated, inactivated, subunit, conjugate, toxoid, recombinant and DNA vaccines. Live attenuated vaccine technology is the major technology in the veterinary vaccines market. The disease type segment includes Rabies, Brucellosis, Leptospirosis, Influenza, Rift Valley fever, Newcastle disease, Nipah virus infection, Hendra virus infection, Porcine Reproductive and Respiratory Syndrome virus and Japanese encephalitis Q fever.
Based on geography, the market is segmented into North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). European region is the leading veterinary vaccine market closely followed by United States. Middle East, Brazil, Argentina, Mexico, Turkey, China, and India are lucrative markets for veterinary vaccines, owing to growing demand for livestock, development of new products and favorable government initiatives.
Pfizer Animal Health, Merck Animal Health, Sanofi-Aventis Animal Health, Bayer Healthcare - Animal Health, Virbac, Novartis Animal Health, BoehringerIngelheim Animal Health and Heska Corporation are few of the key players for this market. The top 3 players in the Veterinary Vaccines market are Pfizer, Merck and Sanofi-Aventis, based on the revenues they generate each year. Pfizer is the market leader in the Veterinary vaccines market (by revenue) but Merck is the market leader in Livestock Vaccines market and Sanofi-Aventis is leading in the Companion Vaccines market. There have few Mergers/Acquisitions by the key players in the Veterinary Vaccines market to expand their product portfolio in order to top the global market. Ex: Pfizer acquiring Wyeth which supposedly the largest acquisition. The industry players have adopted certain growth strategies to excel in veterinary vaccines